Multiple cellular DNA and enzyme targets

The term Multiple cellular DNA and enzyme targets refers to a broad classification of biological entities affected by non-specific therapeutic agents, most notably cytotoxic chemotherapy. Rather than binding to a single receptor or enzyme pocket, drugs in this category, such as alkylating agents and platinum-based compounds, interact with a wide variety of cellular components including genomic DNA, RNA, and numerous metabolic enzymes (Source: DrugBank, PubChem). These interactions typically involve the formation of covalent bonds or physical intercalation, which leads to structural damage to the DNA template and the inhibition of critical enzymes required for replication and transcription (Source: National Cancer Institute). This multi-targeted approach is highly effective at inducing apoptosis in rapidly dividing cells, making it a mainstay in the treatment of various cancers, including lung, ovarian, and testicular malignancies. However, the lack of specificity results in a narrow therapeutic window and significant systemic toxicity, as the drugs also affect healthy, rapidly proliferating tissues such as the bone marrow and intestinal epithelium (Source: StatPearls). Consequently, while these targets are therapeutically relevant, they represent a collective mechanism of action rather than a discrete molecular entity.

Other names

Non-specific cellular targetsMulti-target cytotoxic agentsDNA and protein targetsBroad-spectrum cellular targets

Covalent modification (alkylation) of DNA bases, interstrand and intrastrand DNA cross-linking, inhibition of DNA polymerases, and non-specific binding to cellular enzymes and proteins to disrupt metabolic pathways.